Current:Home > StocksEli Lilly says an experimental drug slows Alzheimer's worsening-LoTradeCoin
Eli Lilly says an experimental drug slows Alzheimer's worsening
View Date:2024-12-24 03:35:24
WASHINGTON — Eli Lilly and Co. said Wednesday its experimental Alzheimer's drug appeared to slow worsening of the mind-robbing disease in a large study.
In the 18-month trial, people in the early stages of Alzheimer's who received infusions of donanemab showed 35% less decline in thinking skills compared to those given a dummy drug, Lilly announced in a press release.
The drug is designed to target and clear away a sticky protein called beta-amyloid that builds up into brain-clogging plaques that are one hallmark of Alzheimer's.
A similar amyloid-targeting drug, Eisai and Biogen's Leqembi, recently hit the market with similar evidence that it could modestly slow Alzheimer's — and also some safety concerns, brain swelling or small brain bleeds.
Donanemab also comes with that risk. Lilly said in its study, the brain side effects caused the deaths of two participants and a third also died after a serious case.
The preliminary study results haven't been vetted by outside experts. Indianapolis-based Lilly plans to release more details at an international Alzheimer's meeting this summer and is seeking Food and Drug Administration approval of the drug.
veryGood! (4)
Related
- California voters reject proposed ban on forced prison labor in any form
- Netflix debuts first original African animation series, set in Zambia
- Netflix debuts first original African animation series, set in Zambia
- Video shows bear stuck inside car in Lake Tahoe
- Spirit Airlines cancels release of Q3 financial results as debt restructuring talks heat up
- Hey Now, Hilary Duff’s 2 Daughters Are All Grown Up in Sweet Twinning Photo
- Increasingly Large and Intense Wildfires Hinder Western Forests’ Ability to Regenerate
- Rural Communities Like East Palestine, Ohio, Are at Outsized Risk of Train Derailments and the Ensuing Fallout
- Trump’s economic agenda for his second term is clouding the outlook for mortgage rates
- Activists Slam Biden Administration for Reversing Climate and Equity Guidance on Highway Expansions
Ranking
- Satire publication The Onion buys Alex Jones’ Infowars at auction with help from Sandy Hook families
- U.K. leader Rishi Sunak's Conservatives suffer more election losses
- Boat crashes into Lake of the Ozarks home, ejecting passengers and injuring 8
- How Auditing Giant KPMG Became a Global Sustainability Leader While Serving Companies Accused of Forest Destruction
- Trump’s economic agenda for his second term is clouding the outlook for mortgage rates
- Keep Up With Khloé Kardashian’s Style and Save 60% On Good American Jeans, Bodysuits, and More
- The Most-Cited Number About the Inflation Reduction Act Is Probably Wrong, and That Could Be a Good Thing
- Marylanders Overpaid $1 Billion in Excessive Utility Bills. Some Lawmakers and Advocates Are Demanding Answers
Recommendation
-
US wholesale inflation picks up slightly in sign that some price pressures remain elevated
-
Republicans Propose Nationwide Offshore Wind Ban, Citing Unsubstantiated Links to Whale Deaths
-
Body cam video shows police in Ohio release K-9 dog onto Black man as he appeared to be surrendering
-
Companies Object to Proposed SEC Rule Requiring Them to Track Emissions Up and Down Their Supply Chains
-
Tennessee fugitive accused of killing a man and lying about a bear chase is caught in South Carolina
-
Biden administration officials head to Mexico for meetings on opioid crisis, migration
-
3 dead in Serbia after a 2nd deadly storm rips through the Balkans this week
-
A Proposed Utah Railway Could Quadruple Oil Production in the Uinta Basin, if Colorado Communities Don’t Derail the Project